Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.

Results 1 – 6 of 6 Page 1 of 1

Title	Location	Country
Title	Location	Country	Reset
Director US Regulatory Strategy Director US Regulatory Strategy Deerfield, IL, US Sep 18, 2026 0.00 mi	Deerfield, IL, US	United States
Director US Regulatory Strategy Director US Regulatory Strategy Deerfield, IL, US Aug 26, 2026 0.00 mi	Deerfield, IL, US	United States
Medical Affairs Director - Movement Disorders Medical Affairs Director - Movement Disorders Deerfield, IL, US Sep 20, 2026 0.00 mi	Deerfield, IL, US	United States
Senior Manager Regulatory Strategy Senior Manager Regulatory Strategy Deerfield, IL, US Sep 22, 2026 0.00 mi	Deerfield, IL, US	United States
Senior Medical Science Liaison Rare Epilepsies- North Central Senior Medical Science Liaison Rare Epilepsies- North Central Deerfield, IL, US Sep 8, 2026 0.00 mi	Deerfield, IL, US	United States
Senior Scientist, Formulation Development Senior Scientist, Formulation Development Bothell, WA, US Sep 1, 2026 0.00 mi	Bothell, WA, US	United States